Hemodynamic effects of anthrax toxins in the rabbit model and the cardiac pathology induced by lethal toxin

Toxins

Volumn 3, Issue 6, 2011, Pages 721-736

  Lawrence, William S ^a   Marshall, Jeffrey R ^a   Zavala, Diana L ^b   Weaver, Lori E ^b   Baze, Wallace B ^c   Moen, Scott T ^a   Whorton, Elbert B ^b   Gourley, Randy L ^b   Peterson, Johnny W ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anthrax; Cardiac; Lethal toxin; Rabbit model; References

Indexed keywords

ANTHRAX TOXIN; EDEMA TOXIN; LETHAL TOXIN; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CARDIOTOXICITY; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART DILATATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART RATE; HISTOPATHOLOGY; MEAN ARTERIAL PRESSURE; NONHUMAN; RABBIT; TELEMETRY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; MYOCARDIUM; RABBITS; TELEMETRY; TROPONIN I;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 79959665472     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins3060721     Document Type: Article

References (33)

1. Borio, L.; Frank, D.; Mani, V.; Chiriboga, C.; Pollanen, M.; Ripple, M.; Ali, S.; DiAngelo, C.; Lee, J.; Arden, J. et al. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. J. Am. Med. Assoc. 2001, 286, 2554-2559.
2. Grinberg, L.M.; Abramova, F.A.; Yampolskaya, O.V.; Walker, D.H.; Smith, J.H. Quantitative pathology of inhalational anthrax I: Quantitative microscopic findings. Mod. Pathol. 2001, 14, 482-495.
3. Jernigan, J.A.; Stephens, D.S.; Ashford, D.A.; Omenaca, C.; Topiel, M.S.; Galbraith, M.; Tapper, M.; Fisk, T.L.; Zaki, S.; Popovic, T. et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 2001, 7, 933-944.
4. Mina, B.; Dym, J.P.; Kuepper, F.; Tso, R.; Arrastia, C.; Kaplounova, I.; Faraj, H.; Kwapniewski, A.; Krol, C.M.; Grosser, M. et al. Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City. J. Am. Med. Assoc. 2002, 287, 858-862.
5. Mock, M.; Fouet, A. Anthrax. Annu. Rev. Microbiol. 2001, 55, 647-671.
6. Brossier, F.; Mock, M. Toxins of Bacillus anthracis. Toxicon 2001, 39, 1747-1755.
7. Duesbery, N.S.; Vande Woude, G.F. Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinase. J. Appl. Microbiol. 1999, 87, 289-293.
8. Mourez, M. Anthrax toxins. Rev. Physiol. Biochem. Pharmacol. 2004, 152, 135-164.
9. Duesbery, N.S.; Vande Woude, G.F. Anthrax toxins. Cell. Mol. Life Sci. 1999, 55, 1599-1609.
10. Collier, R.J.; Young, J.A. Anthrax toxin. Annu. Rev. Cell. Dev. Biol. 2003, 19, 45-70.
11. Little, S.F.; Ivins, B.E. Molecular pathogenesis of Bacillus anthracis infection. Microbes Infect. 1999, 1, 131-139.
12. Kirby, J.E. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 2004, 72, 430-439.
13. Popov, S.G.; Villasmil, R.; Bernardi, J.; Grene, E.; Cardwell, J.; Wu, A.; Alibek, D.; Bailey, C.; Alibek, K. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 2002, 293, 349-355.
14. Agrawal, A.; Pulendran, B. Anthrax lethal toxin: a weapon of multisystem destruction. Cell. Mol. Life Sci. 2004, 61, 2859-2865.
15. Baldari, C.T.; Tonello, F.; Paccani, S.R.; Montecucco, C. Anthrax toxins: A paradigm of bacterial immune suppression. Trends Immunol. 2006, 27, 434-440.
16. Cui, X.; Moayeri, M.; Li, Y.; Li, X.; Haley, M.; Fitz, Y.; Correa-Araujo, R.; Banks, S.M.; Leppla, S.H.; Eichacker, P.Q. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286, R699-R709.
17. Culley, N.C.; Pinson, D.M.; Chakrabarty, A.; Mayo, M.S.; Levine, S.M. Pathophysiological manifestations in mice exposed to anthrax lethal toxin. Infect. Immun. 2005, 73, 7006-7010.
18. Firoved, A.M.; Miller, G.F.; Moayeri, M.; Kakkar, R.; Shen, Y.; Wiggins, J.F.; McNally, E.M.; Tang, W.J.; Leppla, S.H. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 2005, 167, 1309-1320.
19. Moayeri, M.; Haines, D.; Young, H.A.; Leppla, S.H. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 2003, 112, 670-682.
20. Tournier, J.N.; Quesnel-Hellmann, A.; Cleret, A.; Vidal, D.R. Contribution of toxins to the pathogenesis of inhalational anthrax. Cell. Microbiol. 2007, 9, 555-565.
21. Cui, X.; Li, Y.; Li, X.; Laird, M.W.; Subramanian, M.; Moayeri, M.; Leppla, S.H.; Fitz, Y.; Su, J.; Sherer, K.; Eichacker, P.Q. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J. Infect. Dis. 2007, 195, 572-580.
22. Watson, L.E.; Kuo, S.R.; Katki, K.; Dang, T.; Park, S.K.; Dostal, D.E.; Tang, W.J.; Leppla, S.H.; Frankel, A.E. Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLoS One 2007, 2, e466.
23. Watson, L.E.; Mock, J.; Lal, H.; Lu, G.; Bourdeau, R.W.; Tang, W.J.; Leppla, S.H.; Dostal, D.E.; Frankel, A.E. Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction. Front. Biosci. 2007, 12, 4670-4675.
24. Lawrence, W.S.; Hardcastle, J.M.; Brining, D.L.; Weaver, L.E.; Ponce, C.; Whorton, E.B.; Peterson, J.W. The physiologic responses of Dutch belted rabbits infected with inhalational anthrax. Comp. Med. 2009, 59, 257-265.
25. Mabry, R.; Brasky, K.; Geiger, R.; Carrion, R.; Hubbard, G.B.; Leppla, S.; Patterson, J.L.; Georgiou, G.; and Iverson, B.L. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 2006, 13, 671-677.
26. Molin, F.D.; Fasanella, A.; Simonato, M.; Garofolo, G.; Montecucco, C.; Tonello, F. Ratio of lethal and edema factors in rabbit systemic anthrax. Toxicon 2008, 52, 824-828.
27. Cain, A.E.; Tanner, D.M.; Khalil, R.A. Endothelin-1-induced enhancement of coronary smooth muscle contraction via MAPK-dependent and MAPK-independent [Ca(2+)](i) sensitization pathways. Hypertension 2002, 39, 543-549.
28. Streefkerk, J.O.; Hoogaars, W.M.; Christoffels, V.M.; Sand, C.; Pfaffendorf, M.; Peters, S.L.; van Zwieten, P.A. Vasopressin-induced vasoconstriction is dependent on MAPKerk1/2 phosphorylation. Fundam. Clin. Pharmacol. 2004, 18, 45-50.
29. Sweeny, D.A.; Cui, X.; Solomon, S.B.; Vitberg, D.A.; Migone, T.S.; Scher, D.; Danner, R.L.; Natanson, C.; Subramanian, G.M.; Eichacker, P.Q. Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. J. Investig. Dermatol. 2010, 202, 1885-1896.
30. Hicks, C.W.; Li, Y.; Okugawa, S.; Solomon, S.B.; Moayeri, M.; Leppla, S.H.; Mohanty, A.; Subramanian, G.M.; Mignone, T.S.; Fitz, Y.; Cui, X.; Eichacker, P.Q. Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H1108-H1118.
31. Robinson, R.B.; Siegelbaum, S.A. Hyperpolarization-activated cation currents: From molecules to physiological function. Annu. Rev. Physiol. 2003, 65, 453-480.
32. Namm, D.H.; Leader, J.P. Occurrence and function of cyclic nucleotides in blood vessels. Blood Vessel. 1976, 13, 24-47.
33. Purcell, N.H.; Wilkins, B.J.; York, A.; Saba-El-Leil, M.K.; Meloche, S.; Robbins, J.; Molkentin, J.D. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 2007, 104, 14074-14079.